| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJI.201343497 |
| P698 | PubMed publication ID | 24723371 |
| P50 | author | Monika C Brunner-Weinzierl | Q57950191 |
| P2093 | author name string | Gerhard Jorch | |
| Dirk Schlüter | |||
| Gopala Nishanth | |||
| Holger Lingel | |||
| Magdalena Huber | |||
| Kerry Tedford | |||
| Klaus-Dieter Fischer | |||
| Aditya Arra | |||
| Jonas Pick | |||
| J Kolja Hegel | |||
| P2860 | cites work | CD28 co-stimulation down regulates Th17 development | Q21143804 |
| Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling | Q24625230 | ||
| Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4 | Q24634871 | ||
| Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5 | Q24635387 | ||
| Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 | ||
| CD28 and CTLA-4 coreceptor expression and signal transduction | Q28244243 | ||
| Reversal of the TCR stop signal by CTLA-4 | Q28259985 | ||
| T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt | Q28589692 | ||
| T-cell quality in memory and protection: implications for vaccine design | Q30014840 | ||
| Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice | Q33776452 | ||
| Cutting edge: CTLA-4--B7 interaction suppresses Th17 cell differentiation | Q34041965 | ||
| Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin | Q34465675 | ||
| Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance | Q34472025 | ||
| Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study | Q34614776 | ||
| The soluble isoform of CTLA-4 as a regulator of T-cell responses | Q34648178 | ||
| Tc17 CD8 T cells: functional plasticity and subset diversity. | Q34856750 | ||
| Relative contributions of NK and CD8 T cells to IFN-gamma mediated innate immune protection against Listeria monocytogenes | Q35098219 | ||
| Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab | Q35289145 | ||
| Immune responses to Listeria monocytogenes | Q35906097 | ||
| Recent developments in the transcriptional regulation of cytolytic effector cells | Q35934180 | ||
| Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells | Q36014992 | ||
| Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cell | Q36170597 | ||
| Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms | Q36585688 | ||
| IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy | Q36677310 | ||
| CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases | Q36846646 | ||
| Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells | Q37061893 | ||
| IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype | Q37081632 | ||
| Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice | Q37111353 | ||
| Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge | Q37155421 | ||
| The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells | Q37173259 | ||
| Type 17 CD8+ T cells display enhanced antitumor immunity. | Q37268980 | ||
| IL-23 promotes the production of IL-17 by antigen-specific CD8 T cells in the absence of IL-12 and type-I interferons. | Q37313268 | ||
| Protumor vs antitumor functions of IL-17. | Q37600557 | ||
| CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function. | Q38343937 | ||
| Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model | Q38457326 | ||
| Low-strength T-cell activation promotes Th17 responses. | Q39338146 | ||
| IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12. | Q39450545 | ||
| Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis | Q39714121 | ||
| A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity | Q39835072 | ||
| Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6. | Q40132546 | ||
| Contribution of CD8+ T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. | Q40700698 | ||
| Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. | Q41899031 | ||
| IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis | Q42136819 | ||
| A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-γ production | Q42604117 | ||
| Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. | Q42739331 | ||
| IL-21 inhibits IFN-gamma production in developing Th1 cells through the repression of Eomesodermin expression | Q43828654 | ||
| Early programming of T cell populations responding to bacterial infection | Q44560253 | ||
| IL-23 drives pathogenic IL-17-producing CD8+ T cells. | Q47976537 | ||
| CD152 (CTLA-4) regulates effector functions of CD8+ T lymphocytes by repressing Eomesodermin. | Q51815081 | ||
| High IFN-gamma production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4). | Q52927586 | ||
| The development of IL-17/IFN-γ-double producing CTLs from Tc17 cells is driven by epigenetic suppression of Socs3 gene promoter. | Q53164307 | ||
| Cytotoxic T-lymphocyte antigen 4 blockade augments the T-cell response primed by attenuated Listeria monocytogenes resulting in more rapid clearance of virulent bacterial challenge | Q56899966 | ||
| CD4+ T Cells Disarm or Delete Cytotoxic T Lymphocytes under IL-17-Polarizing Conditions | Q62555862 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2139-2152 | |
| P577 | publication date | 2014-05-30 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | CTLA-4 (CD152) enhances the Tc17 differentiation program | |
| P478 | volume | 44 |
| Q38328539 | IL-17A-producing CD8(+)T cells as therapeutic targets in autoimmunity. |
| Q37546999 | Listeria monocytogenes-Induced Cell Death Inhibits the Generation of Cell-Mediated Immunity. |
| Q51084408 | The differentiation and plasticity of Tc17 cells are regulated by CTLA-4-mediated effects on STATs. |
| Q39438071 | Yin and yang of interleukin-17 in host immunity to infection |
Search more.